Client Transactions

The Harvard Drug Group

July 6, 2015 Piper Jaffray co-advises The Harvard Drug Group on $1.1 billion sale to Cardinal Health.

 

Scottsdale City, Arizona - Preserve Acquisition / Project of 20014

April 16, 2014Piper Jaffray serves as financial advisor for $97.2 million general obligation & refunding bonds.

Recent News

August 17, 2015 Former Ceridian CEO Stuart C. Harvey Jr. appointed Piper Jaffray merchant banking partner

August 6, 2015 Piper Jaffray announces share repurchase authorization